Although pathogenic mutations and a large number of missense mutations in BRIP1 have been discovered through genetic testing, the impact of these mutations on the molecular function and subsequent role of BRIP1 in cancer risk is uncertain (Lu et al., 2015; Easton et al., 2016; Weber-Lassalle et al., 2018). The gene discussed is BRIP1; the disease is cancer.